Igf2r improves the survival and transmission ratio of Igf2 transgenic mice

Molecular Reproduction and Development

Volumn 75, Issue 11, 2008, Pages 1678-1687

  Pravtcheva, Dimitrina D ^a   Wise, Thomas L ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Cleft palate; Igf2; Igf2r; Imprinting; Perinatal lethality; Transgene

Indexed keywords

GENE PRODUCT; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLEFT PALATE; CROSS BREEDING; EMBRYO; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HEMIZYGOSITY; MALE; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN BINDING; RECEPTOR BINDING; SURVIVAL; TRANSGENIC MOUSE;

ANIMALS; CLEFT PALATE; FEMALE; GENES, LETHAL; GENOMIC IMPRINTING; INSULIN-LIKE GROWTH FACTOR II; MALE; MICE; MICE, TRANSGENIC; RECEPTOR, IGF TYPE 2; SURVIVAL;

MAMMALIA; MUS; MUS MUSCULUS;

EID: 53049083115     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20909     Document Type: Article

References (63)

1. Baker J, Liu JP, Robertson EJ, Efstratiadis A. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82.
2. Barlow DP, Stoger R, Herrman BG, Saito K, Ashweifer N. 1991. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349:84-87.
3. Bates P, Fisher R, Ward A, Richardson L, Hill DJ, Graham CF. 1995. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72:1189-1193.
4. Bayes-Genis A, Conover CA, Schwartz RS. 2000. The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res 86:125-130.
5. Burns JL, Hassan AB. 2001. Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation. Development 128:3819-3830.
6. Canfield WM, Kornfeld S. 1989. The chicken liver cation-independent mannose 6-phosphate receptor lacks the high affinity binding site for insulin-like growth factor II. J Biol Chem 264:7100-7103.
7. Clairmont KB, Czech MP. 1989. Chicken and Xenopus mannose 6-phosphate receptors fail to bind insulin-like growth factor II. J Biol Chem 264:16390-16392.
8. Cohen MM, Neri G, Weksberg R. 2002. Overgrowth syndromes. New York: Oxford University Press.
9. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. 1998. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 4:1276-1280.
10. DeChiara TM, Efstratiadis A, Robertson EJ. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80.
11. DeChiara TM, Robertson EJ, Efstratiadis A. 1991. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859.
12. Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A. 1997. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 11:3128-3142.
13. Filson AJ, Louvi A, Efstratiadis A, Robertson E J. 1993. Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes. Development 118:731-736.
14. Finch CE, Ruvkun G. 2001. The genetics of aging. Annu Rev Genomics Hum Genet 2:435-462.
15. Gardner RL, Squire S, Zaina S, Hills S, Graham CF. 1999. Insulin-like growth factor-2 regulation of conceptus composition: Effects of the trophectoderm and inner cell mass genotypes in the mouse. Biol Reprod 60:190-195.
16. Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD. 2001. Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 10:1491-1501.
17. Haig D. 1997. Parental antagonism, relatedness asymmetries, and genomic imprinting. Proc Biol Sci 264:1657-1662.
18. Haig D, Graham C. 1991. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64:1045-1046.
19. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppala M. 1996. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98:2612-2615.
20. Hughes-Benzie RM, Hunter AG, Allanson JE, Mackenzie AE. 1992. Simpson-Golabi-Behmel syndrome associated with renal dysplasia and embryonal tumor: Localization of the gene to Xqcen-q21. Am J Med Genet 43:428-435.
21. Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers HH. 1993. The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat Genet 5:74-78.
22. Killian JK, Byrd JC, Jirtle JV, Munday BL, Stoskopf MK, MacDonald RG, Jirtle RL. 2000. M6P/IGF2R imprinting evolution in mammals. Mol Cell 5:707-716.
23. Killian JK, Nolan CM, Wylie AA, Li T, Vu TH, Hoffman AR, Jirtle RL. 2001. Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet 10:1721-1728.
24. Kornfeld S. 1992. Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Ann Rev Biochem 61:307-330.
25. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL. 1994. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8:2953-2963.
26. Lee JE, Pintar J, Efstratiadis A. 1990. Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development 110:151-159.
27. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM. 1995. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39.
28. Louvi A, Accili D, Efstratiadis A. 1997. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189:33-48.
29. Ludwig T, Eggenschwiler J, Fisher P, D'Ercloe AJ, Davenport ML, Efstratiadis A. 1996. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177:517-535.
30. Lyle R, Watanabe D, te Vruchte D, Lerchner W, Smrzka OW, Wutz A, Schageman J, Hahner L, Davies C, Barlow DP. 2000. The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1. Nat Genet 25:19-21.
31. McCann AH, Miller N, O'Meara A, Pedersen I, Keogh K, Gorey T, Dervan PA. 1996. Biallelic expression of the IGF2 gene in human breast disease. Hum Mol Genet 5:1123-1127.
32. Morgan HD, Sutherland HG, Martin DI, Whitelaw E. 1999. Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23:314-318.
33. Newell S, Ward A, Graham C. 1994. Discriminating translation of insulin-like growth factor-II (IGF-II) during mouse embryogenesis. Mol Reprod Dev 39:249-258.
34. Nielsen FC, Ostergaard L, Nielsen J, Christiansen J. 1995. Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature 377:358-362.
35. Niemitz EL, Feinberg AP. 2004. Epigenetics and assisted reproductive technology: A call for investigation. Am J Hum Genet 74:599-609.
36. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. 2002. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277:39684-39695.
37. Pravtcheva DD, Wise TL. 1998. Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice. J Exp Zool 281:43-57.
38. Pravtcheva DD, Wise TL. 2003. Transgene instability in mice injected with an in vitro methylated Igf2 gene. Mutation Res 529:35-50.
39. Rappolee DA, Sturm KS, Behrendtsen O, Schultz GA, Pedersen RA, Werb Z. 1992. Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev 6:939-952.
40. Rogler CE, Yang D, Rosetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K, Hintz R. 1994. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor transgenic mice. J Biol Chem 269:13779-13784.
41. Rubin R, Baserga R. 1995. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest 73:311-331.
42. Senior PV, Byrne S, Brammar WJ, Beck F. 1990. Expression of the IGF-II/mannose-6-phosphate receptor mRNA and protein in the developing rat. Development 109:67-73.
43. Sun FL, Dean WL, Kelsey G, Allen ND, Reik W. 1997. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389:809-815.
44. Taniyama T, Kitai N, Iguchi Y, Murakami S, Yanagi M, Takada K. 2003. Craniofacial morphology in a patient with Simpson-Golabi-Behmel syndrome. Cleft Palate Craniofac J 40:550-555.
45. Tatar M, Bartke A, Antebi A. 2003. The endocrine regulation of aging by insulin-like signals. Science 299:1346-1351.
46. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, Amon A. 2007. Effects of aneuploidy on cellular physiology and cell division in haploid. Science 317:916-924.
47. Valenzano KJ, Remmler J, Lobel P. 1995. Soluble insulin-like growth factor II/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor II in fetal bovine serum. J Biol Chem 270:16441-16448.
48. Valenzano KJ, Heath-Monnig E, Tollefsen SE, Lake M, Lobel P. 1997. Biophysical and biological properies of naturally occurring high molecular weight insulin-like growth factor II variants. J Biol Chem 272:4804-4812.
49. van Roozendaal CE, Gillis AJ, Klijn JG, van Ooijen B, Claassen CJ, Eggermont AM, Henzen-Logmans SC, Oosterhuis JW, Foekens JA, Looijenga LH. 1998. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures. FEBS Lett 437:107-111.
50. Wang ZQ, Fung MR, Barlow DP, Wagner EF. 1994. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372:464-467.
51. Weksberg R, Smith AC, Squire J, Sadowski P. 2003. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 12:R61-R68.
52. Wilkins JF, Haig D. 2001. Genomic imprinting of two antagonistic loci. Proc Biol Sci 268:1861-1867.
53. Wilkins JF, Haig D. 2003. What good is genomic imprinting: The function of parent-specific gene expression. Nat Rev Genet 4:359-368.
54. Wise TL, Pravtcheva DD. 1997. Perinatal lethality in H19 enhancers-Igf2 transgenic mice. Mol Reprod Dev 48:194-207.
55. Wise TL, Pravtcheva DD. 2006. Delayed onset of Igf2-induced mammary tumors in Igf2r transgenic mice. Cancer Res 66:1327-1336.
56. Wu HK, Squire JA, Catzavelos CG, Weksberg R. 1997. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas. Biochem Biophys Res Commun 235:123-129.
57. Wutz A, Theussl HC, Dausman J, Jaenisch R, Barlow DP, Wagner EF. 2001. Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. Development 128:1881-1887.
58. Yballe CM, Vu TH, Hoffman AR. 1996. Imprinting and expression of insulin-like growth factor II and H19 in normal human breast tissue and breast tumor. J Clin Endocrinol Metab 81:1607-1612.
59. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I, Sinclair KD. 2001. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet 27:153-154.
60. Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, Juul A. 1999. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal 13:166-172.
61. Zaina S, Squire S. 1998. The soluble type 2 insulin-like growth factor (IGF-II) receptor reduces organ size by IGF-II-mediated and IGF-II-independent mechanisms. J Biol Chem 273:28610-28616.
62. Zaina S, Newton RV, Paul MR, Graham CF. 1998. Local reduction of organ size in transgenic mice expressing a soluble insulin-like growth factor II/mannose-6-phosphate receptor. Endocrinology 139:3886-3895.
63. Zaina S, Pettersson L, Ahren B, Branen L, Hassan AB, Lindholm M, Mattsson R, Thyberg J, Nilsson J. 2002. Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem 277:4505-4511.